Dow Up 0.11% Nasdaq Up 0.50%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
15.91 Up 0.17(1.08%) Aug 29, 4:00PM EDT
|After Hours : 15.91 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:15.74
Open:15.87
Bid:15.50 x 100
Ask:16.84 x 900
1y Target Est:36.50
Beta:3.32
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:15.78 - 16.23
52wk Range:10.76 - 38.84
Volume:1,308,004
Avg Vol (3m):2,169,100
Market Cap:1.42B
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXUp 1.08%1.42B
DNDN 0.00%211.38M
LLYUp 0.71%68.12B
RHHBYDown 0.14%248.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):539.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.31
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback